Global Blood Glucose Monitoring (BGM) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Blood Glucose Monitoring (BGM) market report explains the definition, types, applications, major countries, and major players of the Blood Glucose Monitoring (BGM) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Abbott Laboratories

    • Sanofi

    • ARKRAY Inc

    • Acon Laboratories Inc

    • Roche Diagnostics Ltd

    • Becton

    • Johnson & Johnson

    • Ypsomed AG

    • Medtronic

    • Terumo Corporation

    • Bayer AG

    • Novo Nordisk A/S

    • Dickinson and Co

    By Type:

    • Blood Glucose Meters

    • Continuous Glucose Monitoring Devices

    • Lancets

    • Blood Glucose Testing Strips

    By End-User:

    • Hospital Use

    • Clinic Use

    • Household

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Blood Glucose Monitoring (BGM) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Blood Glucose Monitoring (BGM) Outlook to 2028- Original Forecasts

    • 2.2 Blood Glucose Monitoring (BGM) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Blood Glucose Monitoring (BGM) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Blood Glucose Monitoring (BGM) Market- Recent Developments

    • 6.1 Blood Glucose Monitoring (BGM) Market News and Developments

    • 6.2 Blood Glucose Monitoring (BGM) Market Deals Landscape

    7 Blood Glucose Monitoring (BGM) Raw Materials and Cost Structure Analysis

    • 7.1 Blood Glucose Monitoring (BGM) Key Raw Materials

    • 7.2 Blood Glucose Monitoring (BGM) Price Trend of Key Raw Materials

    • 7.3 Blood Glucose Monitoring (BGM) Key Suppliers of Raw Materials

    • 7.4 Blood Glucose Monitoring (BGM) Market Concentration Rate of Raw Materials

    • 7.5 Blood Glucose Monitoring (BGM) Cost Structure Analysis

      • 7.5.1 Blood Glucose Monitoring (BGM) Raw Materials Analysis

      • 7.5.2 Blood Glucose Monitoring (BGM) Labor Cost Analysis

      • 7.5.3 Blood Glucose Monitoring (BGM) Manufacturing Expenses Analysis

    8 Global Blood Glucose Monitoring (BGM) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Blood Glucose Monitoring (BGM) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Blood Glucose Monitoring (BGM) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Blood Glucose Monitoring (BGM) Market Outlook by Types and Applications to 2022

    • 9.1 Global Blood Glucose Monitoring (BGM) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Glucose Meters Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Continuous Glucose Monitoring Devices Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Lancets Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Blood Glucose Testing Strips Consumption and Growth Rate (2017-2022)

    • 9.2 Global Blood Glucose Monitoring (BGM) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Use Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Use Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Household Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Blood Glucose Monitoring (BGM) Market Analysis and Outlook till 2022

    • 10.1 Global Blood Glucose Monitoring (BGM) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.2.2 Canada Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.2.3 Mexico Blood Glucose Monitoring (BGM) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.2 UK Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.3 Spain Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.4 Belgium Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.5 France Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.6 Italy Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.7 Denmark Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.8 Finland Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.9 Norway Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.10 Sweden Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.11 Poland Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.12 Russia Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.3.13 Turkey Blood Glucose Monitoring (BGM) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.2 Japan Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.3 India Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.4 South Korea Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.5 Pakistan Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.6 Bangladesh Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.7 Indonesia Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.8 Thailand Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.9 Singapore Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.10 Malaysia Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.11 Philippines Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.4.12 Vietnam Blood Glucose Monitoring (BGM) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.5.2 Colombia Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.5.3 Chile Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.5.4 Argentina Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.5.5 Venezuela Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.5.6 Peru Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.5.8 Ecuador Blood Glucose Monitoring (BGM) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.6.2 Kuwait Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.6.3 Oman Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.6.4 Qatar Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Blood Glucose Monitoring (BGM) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.7.2 South Africa Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.7.3 Egypt Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.7.4 Algeria Blood Glucose Monitoring (BGM) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Blood Glucose Monitoring (BGM) Consumption (2017-2022)

      • 10.8.2 New Zealand Blood Glucose Monitoring (BGM) Consumption (2017-2022)

    11 Global Blood Glucose Monitoring (BGM) Competitive Analysis

    • 11.1 Abbott Laboratories

      • 11.1.1 Abbott Laboratories Company Details

      • 11.1.2 Abbott Laboratories Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Abbott Laboratories Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.1.4 Abbott Laboratories Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi

      • 11.2.1 Sanofi Company Details

      • 11.2.2 Sanofi Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.2.4 Sanofi Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 ARKRAY Inc

      • 11.3.1 ARKRAY Inc Company Details

      • 11.3.2 ARKRAY Inc Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 ARKRAY Inc Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.3.4 ARKRAY Inc Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Acon Laboratories Inc

      • 11.4.1 Acon Laboratories Inc Company Details

      • 11.4.2 Acon Laboratories Inc Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Acon Laboratories Inc Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.4.4 Acon Laboratories Inc Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Roche Diagnostics Ltd

      • 11.5.1 Roche Diagnostics Ltd Company Details

      • 11.5.2 Roche Diagnostics Ltd Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Roche Diagnostics Ltd Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.5.4 Roche Diagnostics Ltd Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Becton

      • 11.6.1 Becton Company Details

      • 11.6.2 Becton Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Becton Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.6.4 Becton Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Johnson & Johnson

      • 11.7.1 Johnson & Johnson Company Details

      • 11.7.2 Johnson & Johnson Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Johnson & Johnson Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.7.4 Johnson & Johnson Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Ypsomed AG

      • 11.8.1 Ypsomed AG Company Details

      • 11.8.2 Ypsomed AG Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Ypsomed AG Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.8.4 Ypsomed AG Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Medtronic

      • 11.9.1 Medtronic Company Details

      • 11.9.2 Medtronic Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Medtronic Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.9.4 Medtronic Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Terumo Corporation

      • 11.10.1 Terumo Corporation Company Details

      • 11.10.2 Terumo Corporation Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Terumo Corporation Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.10.4 Terumo Corporation Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Bayer AG

      • 11.11.1 Bayer AG Company Details

      • 11.11.2 Bayer AG Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Bayer AG Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.11.4 Bayer AG Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Novo Nordisk A/S

      • 11.12.1 Novo Nordisk A/S Company Details

      • 11.12.2 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.12.4 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Dickinson and Co

      • 11.13.1 Dickinson and Co Company Details

      • 11.13.2 Dickinson and Co Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Dickinson and Co Blood Glucose Monitoring (BGM) Main Business and Markets Served

      • 11.13.4 Dickinson and Co Blood Glucose Monitoring (BGM) Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Blood Glucose Monitoring (BGM) Market Outlook by Types and Applications to 2028

    • 12.1 Global Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Blood Glucose Meters Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Continuous Glucose Monitoring Devices Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Lancets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Blood Glucose Testing Strips Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Household Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Blood Glucose Monitoring (BGM) Market Analysis and Outlook to 2028

    • 13.1 Global Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.2 UK Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.5 France Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.3 India Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Blood Glucose Monitoring (BGM) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Blood Glucose Monitoring (BGM)

    • Figure of Blood Glucose Monitoring (BGM) Picture

    • Table Global Blood Glucose Monitoring (BGM) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Blood Glucose Monitoring (BGM) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Blood Glucose Meters Consumption and Growth Rate (2017-2022)

    • Figure Global Continuous Glucose Monitoring Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Lancets Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Glucose Testing Strips Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Use Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Use Consumption and Growth Rate (2017-2022)

    • Figure Global Household Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Glucose Monitoring (BGM) Consumption by Country (2017-2022)

    • Table North America Blood Glucose Monitoring (BGM) Consumption by Country (2017-2022)

    • Figure United States Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Canada Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Table Europe Blood Glucose Monitoring (BGM) Consumption by Country (2017-2022)

    • Figure Germany Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure UK Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Spain Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure France Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Italy Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Finland Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Norway Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Poland Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Russia Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Table APAC Blood Glucose Monitoring (BGM) Consumption by Country (2017-2022)

    • Figure China Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Japan Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure India Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Table South America Blood Glucose Monitoring (BGM) Consumption by Country (2017-2022)

    • Figure Brazil Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Chile Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Peru Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Table GCC Blood Glucose Monitoring (BGM) Consumption by Country (2017-2022)

    • Figure Bahrain Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Oman Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Table Africa Blood Glucose Monitoring (BGM) Consumption by Country (2017-2022)

    • Figure Nigeria Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Table Oceania Blood Glucose Monitoring (BGM) Consumption by Country (2017-2022)

    • Figure Australia Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Blood Glucose Monitoring (BGM) Consumption and Growth Rate (2017-2022)

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Abbott Laboratories Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Sanofi Blood Glucose Monitoring (BGM) Product Portfolio

    • Table ARKRAY Inc Company Details

    • Table ARKRAY Inc Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ARKRAY Inc Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table ARKRAY Inc Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Acon Laboratories Inc Company Details

    • Table Acon Laboratories Inc Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acon Laboratories Inc Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Acon Laboratories Inc Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Roche Diagnostics Ltd Company Details

    • Table Roche Diagnostics Ltd Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics Ltd Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Roche Diagnostics Ltd Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Becton Company Details

    • Table Becton Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Becton Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Johnson & Johnson Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Ypsomed AG Company Details

    • Table Ypsomed AG Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ypsomed AG Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Ypsomed AG Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Medtronic Company Details

    • Table Medtronic Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Medtronic Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Terumo Corporation Company Details

    • Table Terumo Corporation Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Corporation Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Terumo Corporation Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Bayer AG Company Details

    • Table Bayer AG Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Bayer AG Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Novo Nordisk A/S Company Details

    • Table Novo Nordisk A/S Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk A/S Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Novo Nordisk A/S Blood Glucose Monitoring (BGM) Product Portfolio

    • Table Dickinson and Co Company Details

    • Table Dickinson and Co Blood Glucose Monitoring (BGM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dickinson and Co Blood Glucose Monitoring (BGM) Main Business and Markets Served

    • Table Dickinson and Co Blood Glucose Monitoring (BGM) Product Portfolio

    • Figure Global Blood Glucose Meters Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Continuous Glucose Monitoring Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lancets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Glucose Testing Strips Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Household Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Glucose Monitoring (BGM) Consumption Forecast by Country (2022-2028)

    • Table North America Blood Glucose Monitoring (BGM) Consumption Forecast by Country (2022-2028)

    • Figure United States Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Blood Glucose Monitoring (BGM) Consumption Forecast by Country (2022-2028)

    • Figure Germany Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Blood Glucose Monitoring (BGM) Consumption Forecast by Country (2022-2028)

    • Figure China Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Blood Glucose Monitoring (BGM) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Blood Glucose Monitoring (BGM) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Blood Glucose Monitoring (BGM) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Blood Glucose Monitoring (BGM) Consumption Forecast by Country (2022-2028)

    • Figure Australia Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Blood Glucose Monitoring (BGM) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.